Skip to main content

Animations

MJFF Publications

1811 - 1820 of 8100 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • OPEN
    Title: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013
    Citation Count: 14
  • RESTRICTED
    Title: A late-onset neurological disorder: is progression inevitable?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care Approaches
    Journal Name: Journal of Personalized Medicine
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jpm12071057
    Citation Count: 3
  • OPEN
    Title: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/pro.4360
    Citation Count: 9
  • RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
    Journal Name: EJNMMI Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13550-022-00910-1
    Citation Count: 7
  • RESTRICTED
    Title: Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset
    Journal Name: Pharmacological Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s43440-022-00378-9
    Best OA location URL:
    Citation Count: 4
  • OPEN
    Title: Genetic prediction of impulse control disorders in Parkinson's disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51569
    Citation Count: 20
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.